X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (206) 206
index medicus (146) 146
female (130) 130
oncology (122) 122
male (109) 109
middle aged (102) 102
adult (99) 99
pathology (81) 81
aged (73) 73
tumors (65) 65
cancer (59) 59
sarcoma (52) 52
mutation (51) 51
prognosis (51) 51
immunohistochemistry (45) 45
gastrointestinal stromal tumors - genetics (41) 41
gastrointestinal stromal tumors - pathology (41) 41
expression (40) 40
proto-oncogene proteins c-kit - genetics (38) 38
aged, 80 and over (35) 35
surgery (33) 33
gist (32) 32
medicine & public health (32) 32
chemotherapy (31) 31
animals (29) 29
imatinib mesylate (29) 29
metastasis (29) 29
cell line, tumor (28) 28
imatinib (28) 28
analysis (27) 27
mutations (27) 27
cell biology (26) 26
gastrointestinal stromal tumors (26) 26
receptor, platelet-derived growth factor alpha - genetics (26) 26
dna mutational analysis (25) 25
gene expression (25) 25
genetic aspects (25) 25
c-kit (24) 24
diagnosis (24) 24
treatment outcome (24) 24
neoplasm staging (23) 23
research (23) 23
sarcoma - pathology (23) 23
adolescent (22) 22
diagnosis, differential (22) 22
gene (22) 22
kinases (22) 22
kit (22) 22
proteins (21) 21
young adult (21) 21
hematology (20) 20
stem cells (19) 19
antineoplastic agents - therapeutic use (18) 18
gastrointestinal stromal tumors - drug therapy (18) 18
medicine (18) 18
research article (17) 17
survival (17) 17
follow-up studies (16) 16
mice (16) 16
apoptosis (15) 15
care and treatment (15) 15
clinical trials (15) 15
prognostic-factors (15) 15
retrospective studies (15) 15
breast-cancer (14) 14
child (14) 14
gastrointestinal stromal tumors - diagnosis (14) 14
medical prognosis (14) 14
patients (14) 14
phosphorylation (14) 14
piperazines - therapeutic use (14) 14
prospective studies (14) 14
pyrimidines - therapeutic use (14) 14
therapy (14) 14
biopsy (13) 13
breast cancer (13) 13
carcinoma (13) 13
gastrointestinal stromal tumors - surgery (13) 13
pdgfra mutations (13) 13
radiology, nuclear medicine & medical imaging (13) 13
risk factors (13) 13
signal transduction (13) 13
benzamides (12) 12
cancer and oncology (12) 12
cancer och onkologi (12) 12
cells (12) 12
development and progression (12) 12
medical research (12) 12
metastases (12) 12
recurrence (12) 12
xenograft model antitumor assays (12) 12
biomarkers (11) 11
cancer therapies (11) 11
combined modality therapy (11) 11
digestive system diseases (11) 11
gastrointestinal neoplasms - genetics (11) 11
gists (11) 11
hematology, oncology and palliative medicine (11) 11
multidisciplinary sciences (11) 11
sarcoma - therapy (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136023
Background Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients. First clinical trials with therapies targeting... 
CELL LUNG-CANCER | TUMOR-INFILTRATING LYMPHOCYTES | INTERLEUKIN-2 | GEFITINIB | IMPACT | MULTIDISCIPLINARY SCIENCES | ANTIBODY | B7-H1 | T-CELLS | CHEMOTHERAPY | LIGAND 1 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | B7-H1 Antigen - metabolism | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Care and treatment | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Apoptosis | Immunohistochemistry | Thoracic surgery | PD-1 protein | Lung cancer | Clinical trials | Oncology | Cancer therapies | Lymph nodes | Subgroups | Proteins | Rank tests | Regression models | Bcl-x protein | Lymphocytes | Immunotherapy | Medical research | Immunoglobulins | Squamous cell carcinoma | Cell survival | Cytokines | Hematology | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Regression analysis | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Cell death | Medical prognosis | PD-L1 protein | Ligands | Diagnostic systems | Solid tumors | Lymph | Cancer | Tumors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2015, Volume 21, Issue 6, pp. 1383 - 1394
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2015, Volume 21, Issue 21, pp. 4935 - 4946
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 250 - 255
Journal Article
Der Pathologe, ISSN 0172-8113, 07/2019, Volume 40, Issue 4, pp. 339 - 352
Journal Article
Der Pathologe, ISSN 0172-8113, 07/2019, Volume 40, Issue 4, p. 339
Mehr als 20a[macron]% aller Weichgewebstumoren gehoren zur Gruppe adipozytarer Neoplasien. Schwierigkeiten bestehen bei dieser Tumorgruppe vor allem in der... 
Sarcoma
Journal Article
JAMA, ISSN 0098-7484, 03/2012, Volume 307, Issue 12, pp. 1265 - 1272
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 10/2019, Volume 20, Issue 10, pp. E558 - E558
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, p. e0200163
Precision cancer therapy requires on the one hand detailed knowledge about a tumor's driver oncogenes and on the other hand an effective targeted therapy that... 
COLON-CANCER | CETUXIMAB | THERAPY | PATHWAY | MULTIDISCIPLINARY SCIENCES | MUTATION | RESISTANCE | CHRONIC LYMPHOCYTIC-LEUKEMIA | KRAS | METASTATIC COLORECTAL-CANCER | PROGNOSTIC ROLE | RNA, Small Interfering - genetics | Tumor Stem Cell Assay | Class I Phosphatidylinositol 3-Kinases - genetics | Signal Transduction | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Down-Regulation | Humans | Combined Modality Therapy | Class I Phosphatidylinositol 3-Kinases - immunology | Cetuximab - therapeutic use | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | HT29 Cells | Xenograft Model Antitumor Assays | Colorectal Neoplasms - therapy | Animals | Mice, Nude | Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors | RNA, Small Interfering - therapeutic use | Cell Line, Tumor | Female | Mice | Mutation | Colorectal Neoplasms - pathology | Care and treatment | Usage | Xenotransplantation | Colorectal cancer | Genetic aspects | Cellular signal transduction | Research | Cell proliferation | Therapy | Colorectal carcinoma | c-Myc protein | Oncology | AKT protein | Genomes | Myc protein | Cancer therapies | K-Ras protein | Proteins | Epidermal growth factor | Rodents | Xenografts | Hematology | Epidermal growth factor receptors | Tumor cells | Extracellular signal-regulated kinase | siRNA | Pools | Medicine | Pathology | Signaling | Medical prognosis | In vivo methods and tests | Methods | Cancer | Tumors
Journal Article